Obsessive-compulsive symptoms in schizophrenia: A comparison of olanzapine and placebo

Psychopharmacology Bulletin

Volumn 32, Issue 1, 1996, Pages 89-93

  Baker, Robert W ^a,b   Ames, Donna ^c   Umbricht, Daniel S G ^d,e   Chengappa, K N Roy ^a,b   Schooler, Nina R ^a,b  

^a Mayview State Hospital   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

clozapine; obsessive compulsive; olanzapine; risperidone

Indexed keywords

CLOZAPINE; OLANZAPINE; PLACEBO; RISPERIDONE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; OBSESSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PIRENZEPINE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0029933726     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Allen, L, and Tejera, C. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline. Am. J. Psychiatry 151:1096-1097, 1994.
2. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. Washington, DC: The Association, 1987.
3. Ames, D; Ross, S; Wirshing, WC; and Sun, AB. "Case of Schizophrenia, Obsessive Compulsive Disorder, and Tremor." Unpublished manuscript.
4. Baker, RW; Chengappa, KNR; Baird, JW; Steingard, S; Christ, MA; and Schooler, NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J. Clin. Psychiatry 53:439-442, 1992.
5. Barr, LC; Goodman, WK; Price, LH; McDougle, CJ; and Charney, DS. The serotonin hypothesis of obsessive compulsive disorder: Implications of pharmacologic challenge studies. J. Clin. Psychiatry 53[4, Suppl.]:17-28, 1992.
6. Beasley, C; Satterlee, W; Sanger, T; Paul, S; and Tollefson, G. "Additional Clinical Experience With Olanzapine, an "Atypical" Antipsychotic." Presented at the Annual ACNP meeting, San Juan, Puerto Rico, December 1994.
7. Eales, MJ, and Layeni, AO. Exacerbation of obsessive-compulsive symptoms associated with clozapine. Br. J. Psychiatry 164:687-688, 1994.
8. Eisen, JL, and Rasmussen, SA. Obsessive compulsive disorder with psychotic features. J. Clin. Psychiatry 54:373-379, 1993.
9. Fenton, WS, and McGlashan, TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am. J. Psychiatry 143:437-441, 1986.
10. Goodman, WK; Price, LH; Rasmussen, SA; Mazure, C; Delgado, P; Heninger, GR; and Charney, DS. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch. Gen. Psychiatry 46:1012-1016,1989a.
11. Goodman, WK; Price, LH; Rasmussen, SA; Mazure, C; Fleischmann, RL; Hill, CL; Heninger, GR; and Charney, DS. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch. Gen. Psychiatry 46:1006-1011, 1989b.
12. Insel, TR, and Akiskal, HS. Obsessive-compulsive disorder with psychotic features: A phenomenologic analysis. Am. J. Psychiatry 143:1527-1533, 1986.
13. Kopala, L, and Honer, WG. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. Am. J. Psychiatry 151:1714-1715, 1994.
14. LaPorta, LD. More on obsessive-compulsive symptoms and clozapine. J. Clin. Psychiatry 55:312, 1994.
15. Levkovitch, Y; Kronnenberg, Y; and Gaoni, B. Can clozapine trigger OCD? J. Am. Acad. Child Adolesc. Psychiatry 34:263, 1995.
16. Murphy, DL; Zohar, J; Benkelfat, C; Pato, MT; Pigott, TA; and Insel, TR. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder. Br. J. Psychiatry 155[8, Suppl.]:15-24, 1989.
17. National Institute of Mental Health. Special feature: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol. Bull. 21(4), 1985.
18. Patel, B, and Tandon, R. Development of obsessive-compulsive symptoms during clozapine treatment. Am. J. Psychiatry 150:836, 1993.
19. Patil, VJ. Development of transient obsessive-compulsive symptoms during treatment with clozapine. Am. J. Psychiatry 149:272, 1992.
20. Remington, G, and Adams, M. Risperidone and obsessive-compulsive symptoms. J. Clin. Psychopharmacol. 14:358-359, 1994.
21. Robins, LN; Heizer, JE; Croughan, J; Williams, JBW; and Spitzer, RL. The NIMH Diagnostic Interview Schedule, Version III. PHS Pub. No. (ADM-T) 42-3. Rockville, MD: NIMH, 1981.
22. Tran, PV; Beasley, CM; Tollefson, GD; Crawford, AM; and Paul, S. "Olanzapine: An Update on Recent Clinical Studies." Poster presented at the 35th annual meeting of the New Clinical Drug Evaluation Unit, Orlando, FL, May 31 - June 3, 1995.
23. Winslow, JT, and Insel, TR. Neurobiology of obsessive-compulsive disorder: A possible role for serotonin. J. Clin. Psychiatry 51[8, Suppl.]:27-31, 1990.
24. Wong, DT; Calligaro, DO; Bymaster, FP; Moore, NA; and Seeman, P. "Preclinical pharmacology of olanzapine: A novel antipsychotic agent." Presented at the 9th World Congress of Psychiatry, Rio de Janeiro, Brazil, June 1993.
25. Young, CR; Bostic, JQ; and McDanald, CL. Clozapine and refractory obsessive-compulsive disorder: A case report. J. Clin. Psychopharmacol. 14:209-211, 1994.